C12N 2740/13023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2740/13023 (Virus like particles [vlp]) appears on 51 US grants and 75 published applications in this corpus.
Search patents in C12N- Granted patents
- 51
- Published applications
- 75
- Assignees
- 58
- Inventors
- 123
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 2 |
| 2003 | 0 | 4 |
| 2004 | 1 | 4 |
| 2005 | 1 | 3 |
| 2006 | 1 | 5 |
| 2007 | 0 | 0 |
| 2008 | 3 | 2 |
| 2009 | 1 | 0 |
| 2010 | 1 | 4 |
| 2011 | 0 | 2 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 3 | 3 |
| 2015 | 0 | 0 |
| 2016 | 1 | 4 |
| 2017 | 4 | 2 |
| 2018 | 0 | 1 |
| 2019 | 2 | 1 |
| 2020 | 0 | 5 |
| 2021 | 2 | 5 |
| 2022 | 3 | 5 |
| 2023 | 1 | 4 |
| 2024 | 2 | 7 |
| 2025 | 7 | 9 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Virus-like particle16 Jun 2026US 12,655,388 B2Autolus Limited
- VLP-based monovalent ebola vaccines and methods of making and using same30 Sep 2025US 12,427,190 B2Children's Hospital Medical Center
- Virus-like particles which can be used in the treatment of allergies30 Sep 2025US 12,428,625 B2Assistance Publique-Hopitaux de Paris
- Compositions and methods for treatment of cytomegalovirus23 Sep 2025US 12,421,283 B2Variation Biotechnologies Inc.
- Methods and products for genetic engineering22 Jul 2025US 12,365,707 B2Centre National de la Recherche Scientifique (CNRS)
- Lipid particles with cofusogens and methods of producing and using the same16 Jul 2026US 2026/0199238 A1Sana Biotechnology, Inc.
- Immunotherapeutic compositions for treatment of glioblastoma multiforme18 Dec 2025US 2025/0381266 A1Variation Biotechnologies Inc.
- Self-assembling virus-like particles for delivery of nucleic acid programmable fusion proteins and methods of making and using same18 Dec 2025US 2025/0382334 A1President and Fellows of Harvard College
- Methods and products for genetic engineering11 Dec 2025US 2025/0376492 A1Centre National de la Recherche Scientifique (CNRS)
- Compositions and methods for efficient in vivo delivery10 Jul 2025US 2025/0223584 A2President and Fellows of Harvard College
Most cited
By later US patents
- Retroviral packaging cell lines77US 5,591,624 AChiron Viagene, Inc. · 1997
- Recombinant retroviruses57US 5,716,613 AChiron Viagene, Inc. · 1998
- Recombinant retroviruses56US 5,716,826 AChiron Viagene, Inc. · 1998
- Host cells containing multiple integrating vectors45US 6,852,510 B2Gala Design, Inc. · 2005
- Recombinant retroviruses expressing a protein that converts a pro-drug into a cytotoxic agent43US 5,691,177 A1997